Continuum Capital is the toxic lender, Sycamore got a % for setting the drug deal up. They got paid however those middlemen get paid, it's not an uncommon arrangement. In fact, I believe in the new StrikeForce stock offering there's a mention of middleman fees too. Or somewhere else that I've seen recently.

I don't know the specifics, but I'd bet they were paid upon completion of negotiations for the loan. It's Continuum that needs the share price to be pumped for what you've described.

StrikeForce always has cash it can access. Didn't they just get a government bailout check? And there's a healthy balance, or was, from the patent litigation loan. Look at the last report on the line about "paid in capital". The yearly average clearly exceeds yearly operational expenses.